DFX Intelligence
Sialia Therapeutics, Inc.
Venture-backed company · Stage unknown· Irvine, CA
As of · the latest observation of this company; each round carries its own date
Form D industry: Biotechnology
As of · the latest observation of this company; each round carries its own date
What matters now
- $1.5Msold on Form D
Filed a Form D on 2 Sep 2026: $1.5M sold on Form D. A Form D is an offering filing; it names no investors, stage or valuation.
A company that just raised has fresh capital, a new board and new vendors to choose.
Drawing the relationship network…
Facts
Financing history
1 round
- Sep 2, 2026Form D equity offering · $1.5M (form d sold) · 1 investorFact Form D · “Sialia Therapeutics, Inc. filed Form D: $1,500,000 sold of $1,500,000, Biotechnology”
Investors on record
0 edges
No named investor yet.
Ownership and outcomesHow these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.
none on record
No later owner or exit on record: no private equity sponsor position and no acquisition, listing or IPO report names this company.
Credit relationshipsHow a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.
none on record
No lender position matched to this company.
People
1 officer, 0 directors
- Litain Yeh Executive Officer/Director/Promoter sec.gov
Timeline
2 events
- Sep 29, 2026Litain Yeh is an executive officer of Sialia Therapeutics, Inc. (first Form D 2026-09-29), and was an executive officer of Arthrosi Therapeutics, Inc. (first Form D 2018-06-29)Repeat founder Inference no URL
- Sep 29, 2026Sialia Therapeutics, Inc. filed Form D: $1,500,000 sold of $1,500,000, BiotechnologyForm D filed Fact Form D
Evidence
15 observations
Every observation on this company
- Entity type: Corporation Sep 29, 2026 Fact Form D
- Form D industry group: Biotechnology Sep 29, 2026 Fact Form D
- Amendment: false Sep 29, 2026 Fact Form D
- Revenue range (Form D): Decline to Disclose Sep 29, 2026 Fact Form D
- Incorporated: withinFiveYears Sep 29, 2026 Fact Form D
- Jurisdiction: Delaware Sep 29, 2026 Fact Form D
- Amount sold (Form D): $1.5M Sep 29, 2026 Fact Form D
- Offering amount (Form D): $1.5M Sep 29, 2026 Fact Form D
- Exemptions: 06b Sep 29, 2026 Fact Form D
- First sale: 2026-09-02 Sep 29, 2026 Fact Form D
- Investors (Form D): 1 Sep 29, 2026 Fact Form D
- Minimum investment (Form D): 0 Sep 29, 2026 Fact Form D
- Securities offered: option Sep 29, 2026 Fact Form D
- Office address: Sep 29, 2026 Fact Form D
- Year of incorporation: 2026 Sep 29, 2026 Fact Form D
Record history
1 dated event on the change ledger, latest event first
- Form D filed2026-09-29source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.